The Global Market For Metabolomics Expect To Reach Nearly $1.4 Billion In 2017

February 11, 2013

Wellesley, Mass. – Metabolomics is considered an emerging market within the biotechnology sector with enormous commercial potential. The global market for metabolomics was valued at $712 million in 2012 and is expect to reach nearly $1.4 billion in 2017, after increasing at a five-year compound annual growth rate (CAGR) of 14.2%.

The segment made up of bioanalytical instruments and equipment has the highest market share. It was valued at $425 million in 2012 and should reach $800 million in 2017, a CAGR of 13.5%. Bioinformatics tools show the highest potential growth with a 16.1% CAGR through 2017.

One of the main drivers of this is a personalized approach to biomarker development. The advantage of a metabolite profile providing a snapshot of the physiological state of an organism in a fast and sensitive manner offers huge potential for the development of diagnostic products.

Another driver is the drug discovery process. Metabolomics can help pharmaceutical companies to maximize research-and-development (R&D) spending by improving the efficiency of target discovery, validation, and toxicology studies. Comparing metabolite profiling of treated vs. untreated cells prior to clinical trials can show possible side effects of some drug candidates and consequently save time and money spent on potentially inefficient or problematic compounds.Continued)

The metabolomics market can be viewed from different perspectives and divided into three main segments: technology/technique providers such as Agilent and Waters, bioinformatics tool development companies, and companies and nonprofit institutions that provide research and metabolite profiling. In addition, this market can be analyzed by type of application such as diagnostics and biomarker development, food analysis, and drug discovery.


METABOLOMICS: TECHNOLOGIES AND GLOBAL MARKETS (BIO055A) highlights the main segments in the metabolomics market: reagents and technological platforms required for metabolomics research, bioinformatics products essential for data processing and analysis, and the main applications of the metabolomics approach in different areas of industry. It discusses its major players and current and future trends and influences. Drivers and challenges in each subsegment of this industry are described in detail, including forecasts for the next five years.

To Contact us, click here  help

Source: BCC Research

Metabolomics: Technologies and Global Markets( BIO055A )
Publish Date: Feb 2013    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.